Lilly/Boehringer Duloxetine Co-Promotion Lets Lilly Focus On Cialis Launch

Lilly and Boehringer Ingelheim's co-promotion agreement for duloxetine in stress urinary incontinence allows Lilly to focus on Cialis while retaining a stake in its duloxetine urology franchise